Jane B. Acri, Ph.D.

Director

Addiction Treatment Discovery Program

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Bethesda, MD 20892-9551

\(301\) 443-6270

\(301\) 443-2599

jacri@nih.gov

Thomas I. Aigner, Ph.D.

Health Scientist Administrator

Division of Basic Neuroscience and

Behavioral Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

NSC, Room 4283

Rockville, MD 20892

\(301\) 435-1314

\(301\) 594-6043

taigner@ngmsmtp.nida.nih.gov

James C. Anthony, Ph.D.

Professor and Chair

Department of Epidemiology

College of Human Medicine

Michigan State University

B 601 West Fee Hall

East Lansing, MI 48824

\(517\) 353-8623, Ext. 100

\(517\) 432-1130

janthony@msu.edu

Reuben Baler, Ph.D.

Health Scientist Administrator

Science Policy Branch

Office of Science Policy and Communications

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 5241

Bethesda, MD 20892

\(301\) 594-6790

balerr@mail.nih.gov

James M. Bjork, Ph.D.

Research Fellow and Program Official

Division of Clinical Neuroscience and

Behavioral Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 3151

Bethesda, MD 20874

\(301\) 443-3209

\(301\) 443-6814

jbjork@mail.nih.gov

Georgiy Bobashev, Ph.D.

Senior Research Statistician

Statistics and Epidemiology Unit

RTI International

3040 Cornwallis Road

P.O. Box 12194

Research Triangle Park, NC 27709

\(919\) 541-6167

\(919\) 541-6722

bobashev@rti.org

Naresh Chand, D.V.M., Ph.D.

Health Scientist Administrator

Medications Discovery and Toxicology Branch

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4140, MSC 9551

Bethesda, MD 20892-9551

\(301\) 443-8895

nchand@mail.nih.gov

Redonna K. Chandler, Ph.D.

Chief

Services Research Branch

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 5177, MSC 9589

Bethesda, MD 20892-9589

\(301\) 443-8768

\(301\) 443-6815

rchandle@nida.nih.gov

Nora Chiang, Ph.D.

Chief

Chemistry and Pharmaceutics Branch

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4109, MSC 9551

Bethesda, MD 20892-9551

\(301\) 443-8099

\(301\) 443-2599

nchiang@nih.gov

Carson Chow, Ph.D.

Investigator

Laboratory of Biological Modeling

National Institute of Diabetes and Digestive and Kidney Diseases

12 South Drive

Building 12A, Room 4007

Bethesda, MD 20892-5621

\(301\) 402-8250

\(301\) 402-0535

carsonc@mail.nih.edu

Jean Craft Comolli

Program Official

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4128

Rockville, MD 20892-9551

\(301\) 402-0630

\(301\) 443-2599

je282a@nih.gov

Kevin Conway, Ph.D.

Deputy Director

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 5185

Rockville, MD 20892-9589

\(301\) 402-1817

\(301\) 443-6814

kconway@nida.nih.gov

Hirsch D. Davis, M.A.

Psychologist

Medications Discovery and Toxicology Branch

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4123, MSC 9551

Bethesda, MD 20892-9551

\(301\) 443-8849

hdavis@nida.nih.gov

Marta De Santis, Ph.D.

Regulatory Affairs Specialist

Regulatory Affairs Branch

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Rockville, MD 20892-9551

\(301\) 443-0886

mdesantis@nida.nih.gov

Tomas Drgon, Ph.D.

Staff Fellow

Molecular Neurobiology Research Branch

Intramural Research Program

National Institute on Drug Abuse

National Institutes of Health

Triad Building

333 Cassell Drive

Baltimore, MD 21224

\(410\) 550-2843, Ext. 150

tdrgon@intra.nida.nih.gov

Sarah Q. Duffy, Ph.D.

Health Economist

Services Research Branch

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 5195, MSC 9589

Rockville, MD 20850-9589

\(301\) 451-4998

duffys@nida.nih.gov

Laura J. Dunlap, Ph.D.

Research Economist

RTI International

6110 Executive Boulevard

Suite 902

Rockville, MD 20852

\(301\) 816-4616

\(301\) 230-4647

ljd@rti.org

Ahmed M. Elkashef, M.D.

Chief

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Rockville, MD 20892

\(301\) 443-5055

ae8a@nih.gov

Bennett W. Fletcher, Ph.D.

Senior Research Psychologist

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Rockville, MD 20892

\(301\) 443-4060

\(301\) 443-6815

bfletcher@nida.nih.gov

Dennis Glanzman, Ph.D.

Program Chief

Behavioral Science and Integrative Neuroscience

Research Branch

Division of Neuroscience

National Institute of Mental Health

National Institutes of Health

6001 Executive Boulevard

Rockville, MD 20892-9637

\(301\) 443-1576

\(301\) 443-4822

glanzman@nih.gov

Paul J. Gruenewald, Ph.D.

Scientific Director and Senior Research Scientist

Prevention Research Center

Pacific Institute for Research and Evaluation

1995 University Avenue

Suite 450

Berkeley, CA 94704

\(510\) 486-1111, Ext. 5738

\(510\) 644-0594

paul@prev.org

Boris S. Gutkin, Ph.D.

Senior Research Scientist and Co-Director

Group for Neural Theory

Department of Cognitive Studies

ENS-Paris and College de France

3 Rue d\'Ulm

Paris, 75005

33-1-44-27-13-69

33-1-44-27-13-61

boris.gutkin@ens.fr

Colleen A. Hanlon, Ph.D.

Postdoctoral Fellow

Department of Physiology and Pharmacology

Wake Forest University School of Medicine

Medical Center Boulevard

Winston-Salem, NC 27157

\(336\) 716-8702

\(336\) 716-8689

chanlon@wfubmc.edu

Peter Hartsock, Ph.D.

Scientist Officer

Epidemiology Research Branch

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Suite 5158

Bethesda, MD 20892

\(301\) 402-1964

\(301\) 443-2636

ph45z@nih.gov

L. Tandy Herren, Ph.D.

Director of Simulation Technology

DNAPrint Pharmaceuticals, Inc.

1621 West University Parkway

Sarasota, FL 34243

\(717\) 540-0057

therren@dnaprint.com

Thomas Hilton, Ph.D.

Program Official

Services Research Branch

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 5197

Bethesda, MD 20892-9589

\(301\) 435-0808

\(301\) 443-6815

tom.hilton@nih.gov

Lee D. Hoffer, M.P.E., Ph.D.

Research Instructor of Medical Anthropology

Department of Psychiatry

Washington University School of Medicine

Campus Box 8134

40 North Kingshighway, Suite 4

St. Louis, MO 63108

\(314\) 286-2254

\(314\) 286-2265

hofferl@wustl.edu

Barry J. Hoffer, M.D., Ph.D.

Scientific Director

Intramural Research Program

National Institute on Drug Abuse

National Institutes of Health

5500 Nathan Shock Drive

Room 270

Baltimore, MD 21224

\(410\) 550-1538

\(410\) 550-1645

bhoffer@mail.nih.gov

Petra Jacobs, M.D.

Center for the Clinical Trials Network

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Neuroscience Center Building, Room 3117

Rockville, MD 20892-9557

\(301\) 443-6697

pjacobs@nida.nih.gov

Richard A. Jenkins, Ph.D.

Health Scientist Administrator

Prevention Research Branch

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 5185, MSC 9289

Bethesda, MD 20892-9289

\(301\) 443-1923

\(301\) 480-2542

jenkinsri@mail.nih.gov

Mary A. Kautz, Ph.D.

Program Official

Division of Clinical Neuroscience and

Behavioral Research

National Institute on Drug Abuse

National Institutes of Health

3174 Executive Boulevard

Rockville, MD 20892

\(301\) 443-4877

\(301\) 443-6814

kautzm@nida.nih.gov

Richard H. (Rik) Kline, Ph.D.

Medicinal Chemist

Chemistry and Pharmaceutics Branch

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4123, MSC 9551

Bethesda, MD 20892-9551

\(301\) 443-8293

\(301\) 443-9649

rkline@nida.nih.gov

Elizabeth Y. Lambert, M.Sc.

Health Statistician

Epidemiology Research Branch

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 5185

Bethesda, MD 20892

\(301\) 402-1933

\(301\) 480-2543

elambert@nida.nih.gov

Mary R. Lee, M.D.

Staff Clinician

Neuroimaging Research Branch

Intramural Research Program

National Institute on Drug Abuse

National Institutes of Health

4400 Nathan Shock Drive

Baltimore, MD 21224

\(202\) 641-6068

leemary@mail.nih.gov

Chuan-Yun Li, Ph.D.

Guest Researcher

Molecular Neurobiology Research Branch

Intramural Research Program

National Institute on Drug Abuse

National Institutes of Health

Triad Building

333 Cassell Drive

Baltimore, MD 21224

\(410\) 550-2843, Ext. 158

lichua@nida.nih.gov

Akiva Liberman, Ph.D.

Health Scientist Administrator

Services Research Branch

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Bethesda, MD 20892

\(301\) 402-0807

libermana@nida.nih.gov

Geraline C. Lin, Ph.D.

Program Official

Functional Neuroscience Research Branch

Division of Basic Neuroscience and

Behavioral Research

National Institute on Drug Abuse

Nationan Institutes of Health

6001 Executive Boulevard

Bethesda, MD 20892-9555

\(301\) 435-1305

\(301\) 594-6043

glin@nida.nih.gov

Yuan Liu, Ph.D.

Director, Computational Neuroscience Program

National Institute of Neurological Disorders and Stroke

National Institutes of Health

6001 Executive Boulevard

NSC, Room 2187

Bethesda, MD 20892

\(301\) 496-0012

liuyuan@ninds.nih.gov

Qing-Rong Liu, Ph.D.

Staff Scientist

Molecular Neurobiology Research Branch

Intramural Research Program

National Institute on Drug Abuse

National Institutes of Health

Triad Building

333 Cassell Drive, Suite 3610

Baltimore, MD 21224

\(410\) 550-2843, Ext. 157

qliu@intra.nida.nih.gov

Marsha Lopez, M.H.S., Ph.D.

Health Scientist Administrator

Epidemiology Research Branch

Division of Epidemiology, Services and

Prevention Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Bethesda, MD 20892

\(301\) 402-1846

lopezmar@nida.nih.gov

Minda R. Lynch, Ph.D.

Chief

Behavioral and Cognitive Science Research

Branch

Division of Basic Neuroscience and

Behavioral Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4282

Bethesda, MD 20886

\(301\) 435-1322

mlynch1@nida.nih.gov

Stephen Marcus, Ph.D.

Epidemiologist

Cancer Control and Population Sciences

National Cancer Institute

National Institutes of Health

6130 Executive Boulevard

Room 4039-B

Bethesda, MD 20892-7337

\(301\) 594-7934

\(301\) 496-8675

marcussb@mail.nih.gov

Gerald L. McLaughlin, Ph.D.

Chief

Grants Review Branch

Office of Extramural Affairs

National Institute on Drug Abuse

National Institutes of Health

6101 Executive Boulevard

Suite 220, MSC 8401

Bethesda, MD 20892-8401

\(301\) 402-6626

\(301\) 443-0538

gm145a@nih.gov

Jurij Mojsiak, M.S.

Clinical Pharmacologist

Clinical/Medical Branch

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Bethesda, MD 20892

\(301\) 443-9804

\(301\) 443-2599

jm200p@nih.gov

David B. Newlin, Ph.D.

Senior Research Scientist

RTI International

6801 Eastern Avenue

Suite 203

Baltimore, MD 21224

\(443\) 812-5731

\(410\) 633-8778

dnewlin@rti.org

Kay Nimit, M.D.

Scientific Review Officer

Office of Extramural Affairs

National Institute on Drug Abuse

National Institutes of Health

6101 Executive Boulevard

Suite 220, MSC 8401

Bethesda, MD 20892-8401

\(301\) 435-1432

\(301\) 443-0538

knimit@mail.nih.gov

Andrew B. Norman, Ph.D.

Professor, Department of Psychiatry

Director, Division of Neuroscience

University of Cincinnati College of Medicine

231 Albert Sabin Way

MSB G362

Cincinnati, OH 45267-0559

\(513\) 558-6654

\(513\) 558-0042

normanab@ucmail.uc.edu

Jeng-Jong Pan, Ph.D.

Computer Scientist

Center for Clinical Trials Network

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Bethesda, MD 20892

\(301\) 443-8888

jpan@nida.nih.gov

Moo Park, Ph.D.

Program Director

Chemistry and Pharmaceutics Branch

Division of Pharmacotherapies and

Medical Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Bethesda, MD 20892

\(301\) 443-9813

moo_park@nih.gov

Amrat P. Patel, Ph.D.

Pharmacologist

Chemistry and Pharmaceutics Branch

Division of Pharmacotherapies and

Medical Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4123, MSC 9551

Bethesda, MD 20892-9551

\(301\) 443-8476

ap79g@nih.gov

Grace Peng, Ph.D.

Program Director

Division of Discovery Science and Technology

National Institute of Biomedical Imaging and

BioEngineering

National Institutes of Health

6707 Democracy Boulevard

Suite 200

Bethesda, MD 20892

\(301\) 451-4778

\(301\) 480-1614

penggr@mail.nih.gov

Nancy S. Pilotte, Ph.D.

Chief

Functional Neuroscience Research Branch

Division of Basic Neuroscience and

Behavioral Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Rockville, MD 20892-9555

\(301\) 435-1317

npilotte@nih.gov

Aaron David Redish, Ph.D.

Associate Professor

Department of Neuroscience

University of Minnesota

321 Church Street, S.E.

6-145 Jackson Hall

Minneapolis, MN 55455

\(612\) 626-3738

\(612\) 626-5009

redish@umn.edu

Betty Jo Salmeron, M.D.

Staff Clinician

Intramural Research Program

National Institute on Drug Abuse

National Institutes of Health

5500 Nathan Shock Drive

Baltimore, MD 21224

\(410\) 550-1440, Ext. 325

\(410\) 550-1441

bsalmeron@intra.nida.nih.gov

Paul Schnur, Ph.D.

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Neuroscience Center Building, Room 4273

Rockville, MD 20852-9555

\(301\) 435-1316

\(301\) 594-6043

pschnur@mail.nih.gov

Ming L. Shih, Ph.D.

Program Director

Chemistry and Pharmaceutics Branch

Division of Pharmacotherapies and

Medical Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Rockville, MD 20892

\(301\) 443-8842

mshih@mail.nih.gov

David Shurtleff, Ph.D.

Director

Division of Basic Neuroscience and

Behavioral Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4282, MSC 9555

Bethesda, MD 20892-9555

\(301\) 443-1887

\(301\) 594-6043

dshurtle@mail.nih.gov

Roger G. Sorensen, Ph.D.

Program Official

Functional Neuroscience Research Branch

Division of Basic Neuroscience and Behavioral

Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Suite 4287

Bethesda, MD 20892

\(301\) 443-3205

rsorense@mail.nih.gov

Vladimir L. Tsibulsky, Ph.D.

Research Assistant Professor

Department of Psychiatry

University of Cincinnati College of Medicine

231 Albert Sabin Way

ML559

Cincinnati, OH 45267-0559

\(513\) 558-1740

\(513\) 558-0042

vladimir.tsibulsky@uc.edu

Nora D. Volkow, M.D.

Director

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Bethesda, MD 20892

\(301\) 443-6480

\(301\) 443-9127

Susan F. Volman, Ph.D.

Program Director/Health Scientist Administrator

Behavioral and Cognitive Science

Research Branch

Division of Basic Neuroscience and

Behavioral Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Suite 4282

Bethesda, MD 20892

\(301\) 435-1315

\(301\) 594-6043

svolman@nida.nih.gov

Paul Wakim, Ph.D.

Senior Math Statistician

Center for Clinical Trials Network

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 3105

Bethesda, MD 20892

\(301\) 402-3057

\(301\) 443-2317

pwakim@nida.nih.gov

David A. White, Ph.D.

Health Scientist Administrator

Division of Pharmacotherapies and Medical

Consequences of Drug Abuse

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Room 4123

Rockville, MD 20852

\(301\) 443-8889

\(301\) 443-2599

whitedav@nida.nih.gov

Da-Yu Wu, Ph.D.

Health Scientist Administrator

Division of Basic Neuroscience and

Behavioral Research

National Institute on Drug Abuse

National Institutes of Health

6001 Executive Boulevard

Neuroscience Center Building, Room 424

Rockville, MD 20892

\(301\) 443-1887

wudy@nida.nih.gov

Gary A. Zarkin, Ph.D.

Director

Behavioral Health and Criminal Justice Division

RTI International

3040 Cornwallis Road

Research Triangle Park, NC 27709

\(919\) 541-5858

\(919\) 485-5555

gaz@rti.org

Pingwu Zhang, M.D., Ph.D.

Research Scientist

Molecular Neurobiology Branch

National Institute on Drug Abuse

National Institutes of Health

333 Cassell Drive

Baltimore, MD 21224